STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Melanoma pathogenesis involves complex signaling pathways.
• Signal transducer and activator of transcription 1 (STAT1) and tubulin β4A (TUBB4A) are implicated in cancer, but their specific roles in melanoma require elucidation.

Purpose of the Study:

• To investigate the roles of STAT1 and TUBB4A in melanoma cell proliferation, motility, and apoptosis.
• To establish foundational evidence for developing precision therapeutic interventions targeting these proteins in melanoma.

Main Methods:

• Gene silencing of STAT1 and overexpression of TUBB4A in melanoma cell lines (A375, RPMI-7951).
• In vitro assays: Cell Counting Kit-8, colony formation, Transwell migration, and flow cytometry for apoptosis.
• In vivo murine xenograft model to assess tumor growth.
• Western blot analysis for protein expression levels.

Main Results:

• STAT1 downregulation impaired melanoma cell proliferation and motility, increasing apoptosis.
• TUBB4A overexpression partially reversed these effects, indicating it mediates STAT1's pro-tumorigenic activity.
• STAT1 knockdown reduced tumor volume in vivo, with TUBB4A overexpression partially restoring growth.

Conclusions:

• STAT1 promotes melanoma progression by upregulating TUBB4A as a downstream mediator.
• The STAT1-TUBB4A regulatory axis represents a potential therapeutic target for melanoma.
• Novel mechanistic insights into melanoma pathogenesis and potential treatment modalities were provided.